This is the authors' abstract. We don't add key points for this paper.
The knowledge of genetic structure of BRCA1 in MENA should contribute to the assessment of the necessity of preventive programs for mutation carriers and clinical management. The high prevalence of BC and the presence of frequent mutations of the BRCA1 gene emphasize the need for improving screening programs and individual testing/counseling.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Laraqui et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: